Total Payments
$6,951
2024 Payments
$29.92
Companies
35
Transactions
481
Medicare Patients
2,413
Medicare Billing
$309,281
Payment Breakdown by Category
Food & Beverage$6,951 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,951 | 481 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,461 | 170 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $972.74 | 71 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $533.37 | 38 | $0 (2023) |
| Merck Sharp & Dohme LLC | $306.28 | 21 | $0 (2022) |
| Ironwood Pharmaceuticals, Inc | $292.19 | 19 | $0 (2023) |
| Daiichi Sankyo Inc. | $289.75 | 19 | $0 (2023) |
| Allergan, Inc. | $273.80 | 23 | $0 (2020) |
| PFIZER INC. | $224.92 | 16 | $0 (2023) |
| Janssen Biotech, Inc. | $215.31 | 13 | $0 (2023) |
| Gilead Sciences, Inc. | $187.59 | 13 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $29.92 | 2 | ABBVIE INC. ($15.46) |
| 2023 | $514.31 | 29 | AbbVie Inc. ($242.23) |
| 2022 | $913.36 | 64 | ABBVIE INC. ($347.68) |
| 2021 | $872.16 | 65 | AbbVie Inc. ($370.51) |
| 2020 | $837.63 | 62 | AbbVie Inc. ($328.66) |
| 2019 | $1,050 | 77 | AbbVie, Inc. ($240.00) |
| 2018 | $1,226 | 94 | AbbVie, Inc. ($414.22) |
| 2017 | $1,508 | 88 | AbbVie, Inc. ($501.80) |
All Payment Transactions
481 individual payment records from CMS Open Payments — Page 1 of 20
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $15.46 | General |
| Category: IMMUNOLOGY | ||||||
| 04/18/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $14.46 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/01/2023 | Medtronic, Inc. | GI GENIUS (Device) | Food and Beverage | In-kind items and services | $28.65 | General |
| Category: Gastrointestinal AI | ||||||
| 07/18/2023 | AbbVie Inc. | VIBERZI (Drug), LINZESS | Food and Beverage | In-kind items and services | $14.69 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/27/2023 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $16.82 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 06/23/2023 | AbbVie Inc. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $3.82 | General |
| Category: IMMUNOLOGY | ||||||
| 06/21/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: Gastroenterology | ||||||
| 06/20/2023 | AbbVie Inc. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $13.06 | General |
| Category: IMMUNOLOGY | ||||||
| 06/12/2023 | W. L. Gore & Associates, Inc. | GORE CARDIOFORM Septal Occluder (Device) | Food and Beverage | In-kind items and services | $14.19 | General |
| Category: Devices | ||||||
| 06/07/2023 | Mallinckrodt Hospital Products Inc. | TERLIVAZ (Drug) | Food and Beverage | In-kind items and services | $41.28 | General |
| Category: CRITICAL CARE | ||||||
| 06/07/2023 | AbbVie Inc. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $32.78 | General |
| Category: IMMUNOLOGY | ||||||
| 05/12/2023 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: IMMUNOLOGY | ||||||
| 05/03/2023 | Ferring Pharmaceuticals Inc. | REBYOTA (Biological) | Food and Beverage | In-kind items and services | $15.62 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/24/2023 | AbbVie Inc. | VIBERZI (Drug), LINZESS | Food and Beverage | In-kind items and services | $14.70 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/18/2023 | AbbVie Inc. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $15.70 | General |
| Category: IMMUNOLOGY | ||||||
| 04/05/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $13.83 | General |
| Category: Neuroscience | ||||||
| 03/22/2023 | AbbVie Inc. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $16.52 | General |
| Category: IMMUNOLOGY | ||||||
| 03/14/2023 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $16.99 | General |
| Category: IMMUNOLOGY | ||||||
| 03/14/2023 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $16.05 | General |
| Category: Immunology | ||||||
| 03/09/2023 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $19.64 | General |
| Category: INTERNAL MEDICINE | ||||||
| 03/03/2023 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $15.65 | General |
| Category: IMMUNOLOGY | ||||||
| 02/28/2023 | SANOFI PASTEUR INC. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $19.25 | General |
| Category: Immunology | ||||||
| 02/28/2023 | AbbVie Inc. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $16.58 | General |
| Category: IMMUNOLOGY | ||||||
| 02/24/2023 | AbbVie Inc. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $16.18 | General |
| Category: IMMUNOLOGY | ||||||
| 02/22/2023 | Ironwood Pharmaceuticals, Inc | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $21.19 | General |
| Category: GI | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 510 | 585 | $650,200 | $66,330 |
| 2022 | 13 | 598 | 768 | $671,277 | $76,428 |
| 2021 | 14 | 659 | 823 | $689,848 | $85,336 |
| 2020 | 14 | 646 | 822 | $618,043 | $81,186 |
Total Patients
2,413
Total Services
2,998
Medicare Billing
$309,281
Procedure Codes
50
All Medicare Procedures & Services
50 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 91 | 115 | $63,250 | $16,668 | 26.4% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 70 | 70 | $167,090 | $15,122 | 9.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 107 | 133 | $54,929 | $13,618 | 24.8% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 96 | 96 | $177,984 | $6,952 | 3.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 23 | 23 | $17,457 | $4,147 | 23.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 31 | 56 | $16,800 | $3,378 | 20.1% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 47 | 47 | $94,000 | $3,366 | 3.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 26 | 26 | $16,016 | $2,815 | 17.6% |
| 45381 | Injection beneath lining of large bowel using a flexible endoscope | Facility | 2023 | 19 | 19 | $42,674 | $263.42 | 0.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 106 | 145 | $59,885 | $15,040 | 25.1% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 66 | 66 | $157,542 | $13,580 | 8.6% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 70 | 185 | $53,222 | $10,838 | 20.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 63 | 68 | $37,400 | $9,546 | 25.5% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 90 | 90 | $166,860 | $5,841 | 3.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 43 | 43 | $26,488 | $5,579 | 21.1% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 37 | 37 | $19,822 | $4,094 | 20.7% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 41 | 41 | $72,766 | $3,589 | 4.9% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 14 | 15 | $11,536 | $2,498 | 21.7% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 17 | 26 | $8,683 | $2,237 | 25.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 11 | 11 | $8,349 | $1,754 | 21.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 21 | 22 | $6,050 | $1,576 | 26.1% |
| 45381 | Injection beneath lining of large bowel using a flexible endoscope | Facility | 2022 | 19 | 19 | $42,674 | $255.65 | 0.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 115 | 144 | $59,472 | $14,651 | 24.6% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 58 | 58 | $138,446 | $11,984 | 8.7% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 71 | 81 | $44,550 | $11,730 | 26.3% |
About Dr. Armen Simonian, M.D
Dr. Armen Simonian, M.D is a Gastroenterology healthcare provider based in Pennington, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/09/2006. The National Provider Identifier (NPI) number assigned to this provider is 1972566263.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Armen Simonian, M.D has received a total of $6,951 in payments from pharmaceutical and medical device companies, with $29.92 received in 2024. These payments were reported across 481 transactions from 35 companies. The most common payment nature is "Food and Beverage" ($6,951).
As a Medicare-enrolled provider, Simonian has provided services to 2,413 Medicare beneficiaries, totaling 2,998 services with total Medicare billing of $309,281. Data is available for 4 years (2020–2023), covering 50 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Pennington, NJ
- Active Since 04/09/2006
- Last Updated 10/09/2012
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1972566263
Products in Payments
- XIFAXAN (Drug) $793.37
- Humira (Biological) $787.33
- HUMIRA (Biological) $543.88
- Entyvio (Biological) $307.98
- RINVOQ (Biological) $273.84
- LINZESS (Drug) $272.18
- INJECTAFER (Drug) $263.28
- Creon (Drug) $248.32
- VIBERZI (Drug) $212.50
- DIFICID (Drug) $204.08
- XELJANZ (Drug) $194.53
- Linzess (Drug) $187.85
- SKYRIZI (Biological) $179.65
- STELARA (Biological) $167.91
- OCALIVA (Drug) $151.49
- ENTYVIO (Biological) $112.94
- CREON (Drug) $107.31
- Amitiza (Drug) $104.57
- ZEPATIER (Drug) $102.20
- Mavyret (Drug) $98.93
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Pennington
Dr. Anil Balani, M.d, M.D
Gastroenterology — Payments: $101,862
Gastroenterology $101,862
Dr. Jason Rogart, Md, MD
Gastroenterology — Payments: $28,641
Gastroenterology $28,641
Dr. Ravinder Dhillon, M.d, M.D
Gastroenterology — Payments: $9,019
Gastroenterology $9,019
Dr. Jyoti Bhatia, M.d, M.D
Gastroenterology — Payments: $4,426
Gastroenterology $4,426
Himanshu Desai, M.d, M.D
Gastroenterology — Payments: $3,871
Gastroenterology $3,871
Dr. Shivaprasad Marulendra, M.d, M.D
Gastroenterology — Payments: $3,362
Gastroenterology $3,362